Effects of endogenous GIP in patients with type 2 diabetes.
Signe StensenLaerke Smidt GasbjergLiva S L KroghKirsa Skov-JeppesenAlexander H Sparre-UlrichMette H JensenFlemming DelaBolette HartmannTina VilsbøllJens Juul HolstMette Marie RosenkildeMikkel Bring ChristensenFilip K Krag KnopPublished in: European journal of endocrinology (2021)
Using a selective GIP receptor antagonist during a meal, we show that endogenous GIP increases postprandial insulin secretion with little effect on postprandial glycaemia but is important for postprandial bone homeostasis in patients with type 2 diabetes.